Advertisement

BOZEN, Sud-Tirol, Italy, July 20, 2010 /PRNewswire/ -- Health Robotics today announced that it recently signed agreements to grant exclusive CytoCare distribution rights in Spain and Portugal to world-leading IV Therapy company Grifols S.A., and to install the first-ever Cancer Therapy Robot in Spain at Vall d'Hebron University Hospital in Barcelona in November 2010.

"We are very excited to have been selected by Health Robotics as their long-term exclusive CytoCare partner in Spain and Portugal, adding the Cancer Therapy Robot in our core Iberian peninsula market to our prior i.v.STATION distribution rights. CytoCare, the world's first and only robotic system designed for the safe and sterile preparation of patient-specific hazardous IV Admixtures, represents an ideal complement to our other market-leading Pharmacy Automation products. Vall d'Hebron University Hospital has demonstrated a long trajectory of innovation, utilizing new technologies to achieve excellent peer-reviewed and published efficiency and medication safety results, with prestigious awards such as Best European Pharmacy Management, ESADE's Management Innovation, and finally the Best Health Care Ideas in 2009", stated Xavier Guix, Vice President of Marketing for Grifols' Hospital System Division".

"It is very exciting to expand our i.v.STATION relationship at such a prestigious hospital as Vall d'Hebron University Hospital, with its world-renowned cancer research program and the well-documented scientific publications by Dr. Josep Monterde and his te

'/>"/>

SOURCE

Advertisement
Advertisement